You and your doctor can decide where you can infuse, and you won’t have to adjust or cancel your plans due to IV infusion appointments.
You infuse Hizentra just under the skin, not into a vein, after training from your doctor. This means another option for people who need a port, or who are having trouble finding a vein or keeping their veins healthy.
In clinical trials, people reported fewer systemic side effects (like headache and nausea) per infusion with Hizentra than with IVIg. With Hizentra, the most common side effects were redness, swelling, itching, and/or bruising at the infusion site; headache; chest, joint or back pain; diarrhea; tiredness; cough; rash; itching; fever, nausea, and vomiting. These are not the only side effects possible.
Hizentra is a prescription medicine used to treat primary immune deficiency (PI) in patients 2 years and older and chronic inflammatory demyelinating polyneuropathy (CIDP) in adults.
To connect live with a Voice2Voice Advocate* who can answer your nonmedical questions about CIDP, call IgIQ at 1-877-355-IGIQ (4447) Mon–Fri between noon and 3 PM ET
You can also call IgIQ Mon–Fri, 8 AM–8 PM ET
*Voice2Voice advocates are not healthcare professionals or medical experts. For medical questions, please contact your physician. Voice2Voice advocates are compensated by CSL Behring LLC. for their time and/or expenses.